© All rights reserved to Barnea Jaffa Lande Law offices

Together is global

High Tech / Life Sciences

Our firm boasts extensive experience in advising Israeli and foreign companies in the fields of pharmaceuticals, biotechnology, medical instrumentation, and digital health.

The firm represents both Israeli and international entrepreneurs, venture capital funds, private funds, technology companies, companies from academic institutions and hospitals, and medical equipment companies.

 

Our firm’s activities in the healthcare sector include providing ongoing legal support from the R&D stage through to the finished product. This encompassoes drafting applications for government supprt, protecting and building an intellectual property strategy, and advising on compliance with regulatory reporting requirements. We also prepare various agreements for clients, including cooperation agreements and clinical trial agreements with research institutes, academic institutions, and hospitals.

 

We also counsel clients in this sector on investment agreements, capital raising, and purchase transactions, as well as vis-à-vis investors.

 

Back to Technology

News and updates - High Tech / Life Sciences:


June 8, 2020

CardiacSense Signs USD 32M Deal to Sell Watches in India

Our firm serves as counsel for Cardiac Sense, a startup that developed a medical watch for remote patient vital signs monitoring and detection of fever and chronic diseases. We represent the startup in all legal matters. Recently, we assisted the company in an over USD 30 million agreement to supply medical watches for use in hospitals in India.

December 12, 2019

Representing Sartorius in the acquisition of a majority stake in Biological Industries.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

November 20, 2019

Podcast: Ariella Dreyfuss for 50inTech on Femtech

Ariella Dreyfuss talks to 50inTech in a special podcast about the growing femtech industry. She discusses challenges facing entrepreneurs in the field and offers advice on how to talk to investors.
September 15, 2019

Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan

Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.

 

 

July 16, 2019

Femtech Meetup at Barnea

Our firm hosted today a meetup for entrepreneurs in the femtech field. Co-hosting was 50inTech, a French organization that provides a platform for women in the high-tech industry.

During the meetup, in which 25 entrepreneurs gathered, Ariella Dreyfuss delivered a brief overview of challenges, trends, and opportunities in the femtech field.

 

High Tech / Life Sciences

Our firm boasts extensive experience in advising Israeli and foreign companies in the fields of pharmaceuticals, biotechnology, medical instrumentation, and digital health.

The firm represents both Israeli and international entrepreneurs, venture capital funds, private funds, technology companies, companies from academic institutions and hospitals, and medical equipment companies.

 

Our firm’s activities in the healthcare sector include providing ongoing legal support from the R&D stage through to the finished product. This encompassoes drafting applications for government supprt, protecting and building an intellectual property strategy, and advising on compliance with regulatory reporting requirements. We also prepare various agreements for clients, including cooperation agreements and clinical trial agreements with research institutes, academic institutions, and hospitals.

 

We also counsel clients in this sector on investment agreements, capital raising, and purchase transactions, as well as vis-à-vis investors.

 

Back to Technology

News and updates - High Tech:


June 8, 2020

CardiacSense Signs USD 32M Deal to Sell Watches in India

Our firm serves as counsel for Cardiac Sense, a startup that developed a medical watch for remote patient vital signs monitoring and detection of fever and chronic diseases. We represent the startup in all legal matters. Recently, we assisted the company in an over USD 30 million agreement to supply medical watches for use in hospitals in India.

December 12, 2019

Representing Sartorius in the acquisition of a majority stake in Biological Industries.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

November 20, 2019

Podcast: Ariella Dreyfuss for 50inTech on Femtech

Ariella Dreyfuss talks to 50inTech in a special podcast about the growing femtech industry. She discusses challenges facing entrepreneurs in the field and offers advice on how to talk to investors.
September 15, 2019

Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan

Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.

 

 

July 16, 2019

Femtech Meetup at Barnea

Our firm hosted today a meetup for entrepreneurs in the femtech field. Co-hosting was 50inTech, a French organization that provides a platform for women in the high-tech industry.

During the meetup, in which 25 entrepreneurs gathered, Ariella Dreyfuss delivered a brief overview of challenges, trends, and opportunities in the femtech field.

 

Enter your email for newsletter sign up: